Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Is N-acetyl-S-phenyl-L-cysteine a urinary biomarker of benzene exposure?

N-acetyl-S-phenyl-L-cysteine is a supported urinary biomarker of recent benzene exposure.

PlausibleNovember 10, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

N-acetyl-S-phenyl-L-cysteine is formed through glutathione conjugation and is used as a urinary biomarker of benzene exposure.

laying out figure…
1 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says this metabolite is formed through glutathione-related processing and measured in urine as an indicator of benzene exposure. The mechanism frames it as a downstream mercapturate end product, produced after benzene is metabolized and then excreted. Smoking can raise measured levels and affect interpretation, especially at lower exposure levels.

Verified conclusion

N-acetyl-S-phenyl-L-cysteine—more commonly called S-phenylmercapturic acid (SPMA)—is a well-established urinary marker of recent benzene exposure. The claim is scientifically supported, with the important qualification that SPMA is produced downstream of the initial glutathione-conjugation step.

Metabolic mechanism

  • Benzene is oxidized chiefly via CYP2E1 to benzene oxide, a reactive intermediate.
  • Glutathione captures a fraction of benzene oxide, initiating the mercapturate pathway. The glutathione conjugate is subsequently processed through cysteinylglycine and cysteine conjugates; terminal N-acetylation produces SPMA.
  • Thus, SPMA is a glutathione-derived end product rather than the immediate product of glutathione conjugation. It is excreted in urine and is not, by itself, evidence of glutathione depletion or benzene toxicity.
  • This pathway represents only a minor fraction of overall benzene metabolism, but its relative specificity makes it useful for exposure monitoring.

Biomonitoring evidence and interpretation

  • Occupational studies support post-shift urinary SPMA as correlating with personal airborne benzene measurements, particularly at exposures around or above approximately 0.3 ppm.
  • SPMA mainly reflects recent exposure: urinary concentrations peak near the end of a work shift, and its elimination half-life is approximately 9 hours.
  • End-of-shift sampling, creatinine adjustment, and—when practical—paired pre-/post-shift samples improve interpretation.

Practical limitations

  • Smoking raises urinary SPMA and can materially confound assessment of low-level occupational exposure.
  • Below roughly 0.25 ppm airborne benzene, the quantitative exposure–SPMA relationship is inconsistent.
  • Acid-dependent conversion of a urinary precursor to SPMA during specimen processing can affect measured concentrations; validated collection and analytical methods matter.

Bottom line

  • SPMA is a supported, relatively specific urinary biomarker of recent benzene exposure, formed through multistep processing of a benzene–glutathione conjugate; results require context regarding timing, smoking, urine dilution, exposure level, and laboratory method.

References

  1. Large Differences in Urinary Benzene Metabolite S-Phenylmercapturic Acid Quantitation: A Comparison of Five LC–MS-MS Methods — pmc.ncbi.nlm.nih.gov ↗
  2. Full article: The mercapturic acid pathway — tandfonline.com ↗
  3. 4. Mechanistic and Other Relevant Data - Benzene - NCBI Bookshelf — ncbi.nlm.nih.gov ↗
  4. Evidence That Humans Metabolize Benzene via Two Pathways — pmc.ncbi.nlm.nih.gov ↗
  5. Biological exposure indices of occupational ... - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  6. Biological monitoring of exposure to benzene - NIH — pmc.ncbi.nlm.nih.gov ↗
  7. Application of the urinary S-phenylmercapturic acid test as ... — pmc.ncbi.nlm.nih.gov ↗
  8. Biological Monitoring of Exposure to Benzene in Port ... — frontiersin.org ↗
  9. Full article: Human biomonitoring of low-level benzene exposures — tandfonline.com ↗
  10. Microsoft Word - IH_PDF扉ひな型.docx — jstage.jst.go.jp ↗
  11. Biological exposure indices of occupational exposure to benzene: A systematic review — cell.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible9 sourcesWhat can cause substantial unintentional weight loss in older adults?→Plausible10 sourcesDoes high LDL with normal triglycerides suggest impaired LDL clearance?→